Top Markets
#1 Verus Coin Verus Coin +22.44%
#2 Ontology Gas Ontology Gas +19.53%
#3 Status Status +17.90%
#4 ETHGas ETHGas +15.70%
#5 Geodnet Geodnet +13.21%
#6 Derive Derive +12.82%
#7 Curve DAO Curve DAO +11.62%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +9.94%
#9 Anvil Anvil +9.76%
#10 The Black Bull The Black Bull +9.10%
Coin of the day
Verus Coin Verus Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Greenyn Biotechnology Co., Ltd Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd

6846
Kedudukan dalam Saham #25419
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Harga Saham
$1.84
Modal Pasaran
$49.75M
Perubahan (1 hari)
0.87%
Perubahan (1 tahun)
-24.88%
Negara
TW
Perdagangan Greenyn Biotechnology Co., Ltd (6846)

Kategori

Healthcare
Pendapatan untuk Greenyn Biotechnology Co., Ltd (6846)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Greenyn Biotechnology Co., Ltd, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Greenyn Biotechnology Co., Ltd dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US